
Authorization to start clinical trial in the US granted for rare paediatric bone disease
Mont-Saint-Guibert, Mar 4, 2021 (GlobeNewswire) – Novadip Biosciences (“Novadip”), a clinical stage company
Authorization to start clinical trial in the US granted for rare paediatric bone disease
Mont-Saint-Guibert, Mar 4, 2021 (GlobeNewswire) – Novadip Biosciences (“Novadip”), a clinical stage company
Belgium – 27th January 2021 – Syndesi Therapeutics SA, a clinical stage biotechnology company developing novel modulators of the synaptic vesicle protein SV2A for the treatment of cognitive impairment
New funding confirms Aphea.Bio’s frontrunner position in sustainable and innovative agriculture
GENT, NOVEMBER 20 - Aphea.Bio, a Belgium-based agtech startup, announced today that it secured a €14
Tessares, a young company from Louvain-la-Neuve, has won an ultra-selective European subsidy of 1.2 million euros!
In Europe, more than 40% of homes in rural areas do not have a quality internet
ViroVet : Animal health company focused on combatting viral infections in livestock
LEUVEN, Belgium, October 21th, 2020 — ViroVet NV, a leading Belgian biopharmaceutical company active in the
Belgium – 28th September 2020 – Syndesi Therapeutics SA, a clinical stage biotechnology company developing novel modulators of the synaptic vesicle protein SV2A for the treatment of cognitive
Novadip Biosciences, spin-off of UCLouvain and Cliniques universitaires Saint-Luc (UCLouvain) have achieved a world first in bone reconstruction. Very promising results for the treatment of rare
Even when cured, people with Covid-19 have significant sequelae: neurological or cardiovascular disorders, fatigue, loss of respiratory efficiency…
Ath, September 10, 2020 - Botalys has developed a
Mont-Saint Guibert, Belgium, 29 July, 2020: Novadip Biosciences ("Novadip" or "the Company"), a clinical-stage biopharmaceutical company leveraging its unique tissue regeneration technology platform
CAMBRIDGE, Mass. and GOSSELIES, Belgium, July 23, 2020 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development